摘要
[目的]观察自拟颈康止痛散治疗颈型颈椎病的有效性和安全性。[方法]将纳入试验的颈型颈椎病患者随机分配到治疗组和对照组,治疗组给予口服颈康止痛散治疗,对照组口服扶他林胶囊和妙纳。治疗10d后观察两组患者总有效率、疼痛强度评分及临床不良事件发生率,评价自拟颈康止痛散的疗效及安全性。[结果]本次试验共纳入患者69例。治疗后治疗组与对照组比较,总有效率两组无统计学差异(P>0.05),在疼痛强度评分降低幅度方面,组间也未存在统计学差异(P>0.05)。但临床不良事件发生率中药组较小,明显优于对照组(P<0.05)。[结论]颈康止痛散在改善颈型颈椎病疼痛方面可达到与西药一样的疗效,但安全性更高,值得临床推广使用。
[Objective] To observe the clinical effect of Jingkangzhitong Decoction on treating cervical type cervical spondylopathy disease(CTCS).[Methods] 69 CTCS patients were randomly divided into two groups.One group accepted the treatment of Jingkangzhitong Decoction,and the other group accepted Voltaren and Myonal tablets.Finally measured effective rates,pain intensity scores and safety after treatment.[Results] Effective rate and pain intensity scores had no significant differences between the two groups.But in the rate of adverse events,treatment group was better than other one.[Conclusion] Jingkangzhitong Decoction can alleviate the pain symptom of CTCS patients,and improve their living qualities.
出处
《浙江中医药大学学报》
CAS
2013年第6期731-733,共3页
Journal of Zhejiang Chinese Medical University
关键词
颈椎病
颈型
颈康止痛散
安全性
cervical spondylopathy disease
cervical type
Jingkangzhitong Decoction
safety